TickerKhojITI Mutual Fund · Equity · Sectoral / Thematic · Regular plan
ITI Pharma and Healthcare Fund - Regular Plan - Growth
₹17.6687NAV on 2 Nov 2026Expense ratio 2.57%
3 Nov 2025NAV low 14.5 · high 18.45+7.1%
In plain words
Over 3 years it returned +17.8% a year, against +8.0% for its benchmark index.
Its worst fall from a peak in the last 3 years was -17.6%.
On 3-year return it ranks 20 of 139 funds in Sectoral / Thematic.
A monthly SIP over 3 years ended ₹12,658 higher in the direct plan than the regular plan, because of the lower expense ratio.
Past returns, not a promise of future returns or a recommendation.
Returns vs benchmark
| Period | Fund | Benchmark |
|---|---|---|
| 1 month | +0.2% | +4.6% |
| 3 months | -1.5% | -3.8% |
| 6 months | +11.0% | -1.6% |
| 1 year | +8.3% | -8.1% |
| 3 years (yearly) | +17.8% | +8.0% |
| Since start (yearly) | +12.1% | +11.3% |
Monthly SIP of ₹10,000
| Period | Invested | Value now | Yearly return |
|---|---|---|---|
| 1 year | ₹1,20,000 | ₹1,29,806 | +15.4% |
| 3 years | ₹3,60,000 | ₹4,17,813 | +9.9% |
Other plan of this fund: ITI Pharma and Healthcare Fund - Direct Plan - Growth